273 related articles for article (PubMed ID: 32348197)
1. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K
Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197
[No Abstract] [Full Text] [Related]
2. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
[TBL] [Abstract][Full Text] [Related]
3. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
[No Abstract] [Full Text] [Related]
4. Longitudinal polysubstance use patterns and non-fatal overdose: A repeated measures latent class analysis.
Karamouzian M; Cui Z; Hayashi K; DeBeck K; Reddon H; Buxton JA; Kerr T
Int J Drug Policy; 2024 Jan; ():104301. PubMed ID: 38182524
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
[TBL] [Abstract][Full Text] [Related]
6. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
[TBL] [Abstract][Full Text] [Related]
7. Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study.
Jones NR; Hickman M; Larney S; Nielsen S; Ali R; Murphy T; Dobbins T; Fiellin DA; Degenhardt L
Drug Alcohol Depend; 2021 Jan; 218():108354. PubMed ID: 33121866
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019.
Shrestha S; Stopka TJ; Hughto JMW; Case P; Palacios WR; Reilly B; Green TC
Harm Reduct J; 2021 Aug; 18(1):93. PubMed ID: 34461922
[TBL] [Abstract][Full Text] [Related]
9. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
Socías ME; Wood E; Lake S; Nolan S; Fairbairn N; Hayashi K; Shulha HP; Liu S; Kerr T; Milloy MJ
Addiction; 2018 Dec; 113(12):2250-2258. PubMed ID: 30238568
[TBL] [Abstract][Full Text] [Related]
10. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.
Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T
Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837
[TBL] [Abstract][Full Text] [Related]
11. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
12. Trajectories of retention in opioid agonist therapy in a Canadian setting.
Socías ME; Dong H; Wood E; Brar R; Richardson L; Hayashi K; Kerr T; Milloy MJ
Int J Drug Policy; 2020 Mar; 77():102696. PubMed ID: 32050143
[TBL] [Abstract][Full Text] [Related]
13. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.
Moallef S; Nosova E; Milloy MJ; DeBeck K; Fairbairn N; Wood E; Kerr T; Hayashi K
Public Health Rep; 2019; 134(4):423-431. PubMed ID: 31211644
[TBL] [Abstract][Full Text] [Related]
14. An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.
Cheng T; Small W; Dong H; Nosova E; Hayashi K; DeBeck K
Subst Abuse Treat Prev Policy; 2018 Nov; 13(1):41. PubMed ID: 30482215
[TBL] [Abstract][Full Text] [Related]
15. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
16. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
[TBL] [Abstract][Full Text] [Related]
17. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
Piske M; Zhou H; Min JE; Hongdilokkul N; Pearce LA; Homayra F; Socias ME; McGowan G; Nosyk B
Addiction; 2020 Aug; 115(8):1482-1493. PubMed ID: 31899565
[TBL] [Abstract][Full Text] [Related]
18. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
19. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study.
Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K
Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484
[TBL] [Abstract][Full Text] [Related]
20. Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada.
Cui Z; Bach P; Ti L; Hayashi K; Morgan J; Milloy MJ; Kerr T
Int J Drug Policy; 2022 Dec; 110():103879. PubMed ID: 36265327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
